Tumor treatment field simulation and treatment adjustment using molecular imaging
The method optimizes TT field transducer placement and distribution using molecular imaging and simulation calibration, enhancing treatment efficacy and reducing imaging needs.
Patent Information
- Application Number
- JP2024527403
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2022-10-17
- Filing Date
- 2022-10-18
- Publication Date
- 2024-11-21
AI Technical Summary
Existing tumor treatment field (TT field) systems lack precision in determining optimal transducer placement and distribution, leading to inefficiencies in tumor treatment efficacy.
A computer-implemented method using molecular imaging to determine transducer placement and distribution based on target molecule concentration, adjusting positions to ensure uniform TT field coverage and calibrating simulation algorithms for improved accuracy.
Enhances the effectiveness of TT fields by optimizing transducer placement and distribution, reducing the need for high-resolution imaging and improving treatment outcomes.
Smart Images

Figure 2024543386000001_ABST
Abstract
Description
[Technical field]
[0001] [CROSS REFERENCE TO RELATED APPLICATIONS] This application claims priority to U.S. Patent Application No. 17 / 967,018, filed October 17, 2022, and U.S. Patent Application No. 63 / 278,643, filed November 12, 2021, both of which are incorporated herein by reference.
[0002] The present invention relates to tumor treatment field simulation and treatment adjustment using molecular imaging. [Background technology]
[0003] A tumor treating field (TT field) is a low intensity alternating electric field in the mid-frequency range (e.g., 50 kHz to 1 MHz) that can be used to treat tumors, as described in U.S. Patent No. 7,565,205. TT fields are non-invasively induced in a target region by placing transducers on the patient's body and applying an AC voltage between the transducers. Conventionally, a first pair of transducers and a second pair of transducers are placed on the subject's body. During a first time interval, an AC voltage is applied between the first pair of transducers to generate an electric field with electric field lines extending normally in the front-to-back direction. Then, an AC voltage at the same frequency is applied between the second pair of transducers for a second time interval to generate an electric field with electric field lines extending normally in the side-to-side direction. The system then repeats this two-step sequence throughout the treatment. Summary of the Invention [Means for solving the problem]
[0004] 1. A computer-implemented method for determining transducer placement on a body of a subject to apply a tumor treatment field, the computer including one or more processors and memory accessible by one or more of said processors, the memory storing instructions that, when executed by one or more of said processors, cause the computer to perform the method, the method comprising: determining a first pair of locations on the subject's body for placing a pair of transducer arrays based on image data of the subject's body; receiving from a molecular imaging device a concentration of a target molecule detected within a target region of the subject's body, the concentration of the target molecule detected after a tumor treatment field is induced between a pair of transducer arrays disposed at the first location pair; determining how the tumor treating field is distributed within a target region of the subject's body based on the detected concentrations of the target molecules; determining a recommendation for a second pair of locations on the subject's body for placing a pair of transducer arrays based on a distribution of the tumor treatment fields within a target region of the subject's body; and outputting the second location pair recommendations to the user. [Brief description of the drawings]
[0005] [Figure 1] 1 shows an example of a transducer placed on a subject's head. [Diagram 2] 1 shows an example of a transducer placed on the subject's torso. [Figure 3A] 1 shows examples of various transducer configurations. [Figure 3B] 1 shows examples of various transducer configurations. [Figure 4] 1 shows an example of a transducer pair configuration. [Diagram 5] 1 shows an example of an apparatus for determining the location on a subject's body of a transducer that applies a TT field. [Figure 6A] 13 shows an example of registering an image showing the concentration of a target molecule with image data. [Figure 6B] 13 shows an example of registering an image showing the concentration of a target molecule with image data. [Figure 6C] 13 shows an example of registering an image showing the concentration of a target molecule with image data. [Figure 7] 13 is a flow chart illustrating an example of determining the placement of transducers on a subject's body for applying a TT field. [Figure 8] 13 is a flow chart illustrating an example of determining the distribution of a TT field. [Figure 9] 1 is a flowchart illustrating an example of calibration of a simulation algorithm. [Figure 10] 13 is a flow chart illustrating an example of applying a TT field to a region of interest within a subject's body. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0006] Described herein is an exemplary method for applying a TT field to a subject to treat one or more cancers. Also described herein is an exemplary method for determining the placement of a transducer on the subject's body for applying the TT field.
[0007] Imaging data and simulations will be used to determine the placement of transducers to apply TT fields to target areas in subjects, but early assessment is required to determine whether tumors will respond to TT field therapy.
[0008] The distribution or concentration of certain molecules in the subject's body may indicate tumor response to TT fields, which may be desirable. For example, pyruvate kinase M2 (PKM2) is a marker of cancer metabolic reprogramming because it catalyzes the final step of glycolysis. TT fields reduced the expression of PKM2 in tumors, indicating a transition from aberrant glycolysis to oxidative phosphorylation. The expression of PKM2 in tumors can be detected by molecular imaging, for example, using [18F]DASA-23 as an imaging agent (e.g., a radioactive tracer). Other molecules may be used with the exemplary embodiments to indicate tumor response to TT fields. Other molecular imaging or molecular detection techniques may be used with the exemplary embodiments to detect molecules indicative of tumor response to TT fields.
[0009] The disclosed method uses detection of target molecules to determine locations on a subject for placing pairs of transducers to apply a TT field to an area of the subject. Detecting the target molecules can calibrate simulation software that evaluates the distribution of the TT field in vivo and recommends transducer locations. Using molecular imaging to evaluate the effectiveness of the TT field in vivo can reduce the number of expensive high-resolution images (e.g., magnetic resonance imaging (MRI)) required throughout the course of cancer treatment.
[0010] FIG. 1 shows an example of a transducer 100 placed on the head of a subject's body. FIG. 1 shows an example of a subject's head where the transducer 100 is placed in various positions and / or orientations. The transducer 100 placed on the subject's head can apply a TT field to a tumor in the subject's brain region. FIG. 2 shows an example of a transducer placed on a position on the subject's torso. FIG. 2 shows a transducer 200 placed on the anterior part of the subject's right chest and a transducer 201 placed on the anterior part of the subject's left thigh. The transducer placed on the subject's torso can apply a TT field to a tumor in the subject's chest or abdomen. The transducers can be placed in a combination of various other positions on the subject's body beyond the positions shown in FIG. 1 and FIG. 2.
[0011] The structure of the transducer may take several forms. The transducer may be fixed to the subject's body, attached to clothing covering the subject's body, or integrated into the subject's body. In FIG. 3A, the transducer 300A has a plurality of electrode elements 302A on a substrate 304A. The substrate 304A is configured to attach the transducer 300A to the subject's body. Suitable materials for the substrate 304A include, for example, fabric, foam, flexible plastic, and / or conductive medical gel. In the case of conductive medical gel, the transducer 300A can be fixed to the subject's body via the substrate 304A. The transducer may be conductive or non-conductive. FIG. 3B shows another example of the structure of the transducer 300B. In this example, the transducer 300B includes a plurality of electrode elements 302B electrically and mechanically connected to each other without a substrate. In one example, the electrode elements 302B are connected to each other by wires 306B. Any structure for implementing a transducer (or electric field generator) for use with embodiments of the present invention can be used so long as it (a) delivers a TT field to the subject's body and (b) can be positioned at the locations specified herein.
[0012] FIG. 4 illustrates an example configuration of a pair of transducers 402 and 404. In this example, the first transducer 402 includes thirteen electrode elements 406 disposed on a substrate 408 and electrically and mechanically connected to each other by conductive traces 410. Similarly, the second transducer 404 includes twenty electrode elements 412 disposed on a substrate 414 and electrically and mechanically connected to each other by conductive traces 416. The transducers 402, 404 are connected to an AC voltage generator 418 and a controller 420. The controller 420 can include one or more processors and a memory accessible by the one or more processors. The memory can store instructions that, when executed by the one or more processors, control the AC voltage generator 418 to induce an electric field between the two transducers 402, 404.
[0013] FIG. 5 shows an exemplary device for determining a transducer position for applying a TT field. In this example, the device 500 includes one or more processors 502, a memory 504, and one or more output devices 506. The memory 504 can be accessed by the one or more processors 502 via a link 508, so that the one or more processors 502 can read information from and write information to the memory 504. The memory 504 stores instructions that, when executed by the one or more processors 502, cause the device 500 to perform one or more methods disclosed herein. The one or more processors 502 can receive a user input 510 and / or an input 510 from a molecular imaging device. The input 510 can include, for example, the concentration of the detected target molecule. Based on the input 510, the one or more processors 502 recommend to the user one or more transducer positions that are output by the output device 506.
[0014] The activity of the TT field is associated with a decrease in PKM2 protein activity (biomarker) in the region of interest of the subject's body. Thus, a decreased [18F]DASA-23 signal is obtained after TT field exposure. The PKM2 protein activity in the cells can be used to determine whether the transducer is in a position where the TT field generated on the subject is effective. The methods disclosed herein can be used to estimate the decrease in PKM2 in the target region and adjust the position of the transducer accordingly. Making such a determination includes co-registering the molecular imaging data (e.g., PKM2 probe data) with the imaging data (e.g., obtained using conventional MRI, positron emission tomography-computed tomography (PET-CT), PET-MRI, or another imaging modality).
[0015] 6A-6C show three examples of MRI images 600A, 600B, 600C with data regarding the concentration of a target molecule, respectively. However, as mentioned above, other imaging modes can be used. The MRI images 600A, 600B, 600C define a target region (e.g., a tumor). Images showing the concentration of the target molecule (e.g., [18F]DASA-23) in the target region segment are aligned with the image data (e.g., 600A, 600B, 600C) in the target region segment to generate a corrected tumor segmentation 602A, 602B, 602C. The corrected tumor segmentation can include a target molecule value in each pixel or voxel (e.g., V1-V4 in FIGS. 6A-6C) associated with the tumor. The modified tumor segmentations 602A, 602B, 602C indicate relative target molecule concentrations (e.g., darker indicates higher signal intensity, lighter indicates lower signal intensity) and can be used to determine transducer position.
[0016] Figure 6A can represent a baseline determination of the [18F]DASA-23 signal (e.g., 602A) within a target region of a subject's body before a TT field is applied to the subject's body. Without the TT field, the [18F]DASA-23 signal strength throughout the target region is relatively high. Figures 6B and 6C represent measurements of the [18F]DASA-23 signal within the target region after a TT field from a transducer is applied to the subject's body.
[0017] In FIG. 6B, application of the TT field results in a reduced (e.g., substantially lower) [18F]DASA-23 signal and a substantially uniform signal throughout the image of the region of interest (e.g., 602B). This indicates that the position of the transducer used to generate the TT field is appropriate to cover the target region. That is, the positioning of the transducer generates a TT field of sufficiently high intensity (or high power density) within the region of interest. As a result of this determination, there is no need to reposition the transducer on the subject's body before applying additional TT fields.
[0018] In FIG. 6C, the image of the [18F]DASA-23 signal is low enough or not uniform enough across the region of interest (e.g., 602C). This indicates that the position of the transducer used to generate the TT field is not optimal to cover the region of interest. This requires the transducer position to be changed, after which another image of the DASA-23 signal can be acquired and aligned to image 600C. If the transducer layout / placement is improved compared to the original position, the next [18F]DASA-23 signal in the image will be even lower. This process may be repeated until the DASA-23 signal is low enough and uniform enough within the region of interest to indicate effective TT field coverage.
[0019] 7 is a flow chart illustrating an example method 700 for determining the placement of a transducer on a subject's body for applying a TT field. As shown, the method 700 can begin with receiving image data 702 associated with the subject's body. The image data 702 can be at least one of magnetic resonance imaging data, computed tomography data, positron emission tomography data, x-ray imaging data, PET-CT data, PET-MRI data, or other data.
[0020] In step S704, the method 700 includes determining a first pair of locations on the subject's body for placing the pair of transducer arrays based on the image data 702 of the subject's body. This may include, for example, performing one or more simulations of expected electric field distribution through the target region of the body (using a simulation algorithm) based on the image data 702. More specifically, this determination may be made by comparing simulations of different possible transducer location pairs and ranking / recommending the transducer location pairs based on the expected electric field distribution.
[0021] In step S706, the method 700 includes receiving from a molecular imaging device a detected concentration of the target molecule in the target region of the subject. After inducing a TT field between a pair of transducer arrays arranged in a first position pair, the concentration of the target molecule is detected. The target molecule may be [18F]DASA-23 and the molecular imaging device may be a PKM2 probe. In step S708, the method 700 may include determining how the TT field is distributed in the target region of the subject's body based on the detected concentration of the target molecule. This may include registering an image showing the concentration of the target molecule in a segment of the target region with the image data in the segment of the target region to generate a corrected tumor segmentation, as discussed with respect to Figures 6A-6C. Determining how the TT field is distributed may include generating a heat map visualization 710 of the target region, or a statistical summary 712 (including statistics such as average, variation, paired t-test, etc.) of the amount of the target molecule in the region. This provides the spatial distribution of [18F]DASA-23 within the target region, which can be used to estimate the effectiveness of the TT field based on the uniformity of distribution across the target region. If the distribution of the [18F]DASA-23 signal is highly non-uniform, it may be necessary to adjust the position of the transducer on the subject's body.
[0022] In step S714, the method 700 may include updating image data of the subject's body based on the distribution of the TT fields within the target region (e.g., 702). In particular, a non-uniform distribution of the TT fields within the target region may indicate that the target region itself (e.g., the region where the tumor is believed to be present) does not correspond to the actual location of the target (e.g., the tumor) within the subject's body. Thus, the method 700 may be used to detect spatial changes of the tumor over time in addition to or instead of additional imaging. The updated image data may be stored in memory and / or used to determine updated transducer positions.
[0023] The method 700 may include, in step S716, updating a simulation algorithm for determining an expected electric field distribution through the target region based on the distribution of the TT fields in the target region. In particular, a non-uniform distribution of the TT fields in the target region may indicate that the simulation algorithm used to determine the recommended transducer location is not properly calibrated and therefore needs to be updated. Thus, the method 700 may be used to update and refine the simulation algorithm to provide more accurate simulations and recommendations for transducer placement locations on the subject's body.
[0024] The method 700 includes, at step S718, determining a recommendation of a second pair of locations on the subject's body for placing the pair of transducer arrays based on the distribution of tumor treatment fields within the target region of the subject's body. In one example, the candidate second locations on the subject's body can be determined based on the updated image data (S714). In another example, the recommendation of the second pair of locations on the subject's body can be based on an updated simulation algorithm (S716).
[0025] In some cases, step S718 may determine that the second pair of locations on the subject's body is the same as the first pair of locations on the subject's body (e.g., if step S708 determines that the distribution of the TT field in the target region is relatively uniform), or step S718 may determine that the second pair of locations on the subject's body is indicative of being different from the first pair of locations (e.g., if step S708 determines that the distribution of the TT field in the target region is sub-optimal based on [18F]DASA-23 signal levels).
[0026] Different methods can be used to determine the second location pair recommendation in step S718. For example, step S718 may include the steps of selecting a number of pairs of locations on the subject's body for placing pairs of transducer arrays, simulating, for each location pair, an expected electric field distribution through a target region for an electric field induced between the pair of transducer arrays in the location pair, simulating the electric field distribution between the pair of transducer arrays in the location pair through the target region, and determining the second location pair recommendation to be the location pair for which the simulation results in the minimum variance of the electric field distribution in the user-defined target region while maintaining at least a predetermined electric field strength in the target region (720). In this way, the transducer locations can be selected to ensure the minimum variance of the TT field to generate a more uniform [18F]DASA-23 signal distribution.
[0027] In another example, step S718 may include selecting a plurality of pairs of locations on the subject's body for placing pairs of transducer arrays, simulating, for each location pair, an expected electric field distribution through a target region for an electric field induced between the pair of transducer arrays in the location pair, simulating the electric field distribution between the pair of transducer arrays in the location pair through the target region, and determining a second location pair recommendation to be the location pair that results in a maximum simulated electric field strength in a portion of the user-defined target region where the tumor treatment region did not reach a predetermined electric field strength (722). In this manner, the transducer locations may be selected to maximize the TT field in the tumor region, where the [18F]DASA-23 signal indicates that PKM2 prevalence is not reduced.
[0028] In another example, step S718 may include determining a recommendation for a second location pair by applying a heuristic algorithm that recommends changes in location pairs of the transducer array that are expected to result in an increase in the distribution of the TT field within the target region (724).
[0029] In step S726, the method 700 includes outputting the second position pair recommendation to the user, which may be a recommendation regarding a transducer array position based on the [18F]DASA-23 signal to provide better TT field coverage in the future.
[0030] FIG. 8 is a flow chart illustrating an exemplary method 800 for determining a distribution of a TT field in a target region. Steps S804-S810 in the method 800 may replace steps S702-S708 in the method 700 of FIG. 7. The method 800 may begin with receiving image data 802 associated with a subject's body, similar to the image data 702 of FIG. 7. In step S804, the method 800 includes receiving an initial concentration of target molecules in a target region of the subject's body from a molecular imaging device. In step S806, the method 800 includes determining a first pair of locations on the subject's body for placing a pair of transducer arrays based on the image data 802. In one example, the first pair of locations on the subject's body may be determined based on the image data 802 and the initial concentration of target molecules in the region (S804). As another example, the first pair of locations on the subject's body may be determined based only on the image data 802, similar to step S704 of FIG. 7.
[0031] In step S808, similar to step S706 of FIG. 7, a detected concentration of the target molecule in the target region of the subject's body is received from the molecular imaging device. In step S810, it may include determining how the TT field is distributed in the target region of the subject's body based on a comparison of the initial concentration of the target molecule (S804) and the detected concentration of the target molecule in the target region (S808). In step S810, determining how the TT field is distributed may include generating a heat map visualization 812 showing the change (δ) of the amount of the target molecule from the initial concentration to the concentration detected after application of the TT field. In step S810, determining how the TT field is distributed may include generating a statistical summary 814 (including, for example, mean, variance, paired t-test, etc.) representing the change (δ) of the amount of the target molecule from the initial concentration to the concentration detected after application of the TT field. This allows a spatial representation of how the PKM2 protein changes over time in the target region, which may be used to estimate the effectiveness of the TT field. If the [18F]DASA-23 signal variation is highly non-uniform, it may be necessary to adjust the placement of the transducer on the subject's body. Method 800 can then proceed to steps S714 / S716 / S718 of FIG.
[0032] FIG. 9 is a flow chart illustrating an example method 900 of calibrating a simulation algorithm. The method 900 may begin with receiving image data 902 associated with a first subject's body, similar to 702 in FIG. 7. In step S904, the method 900 includes using the simulation algorithm to perform one or more simulations for an expected electric field distribution through a target region of the first subject's body based on the image data 902. In step S906, the method 900 includes determining, based on the simulation, a first location on the first subject's body for placing a first transducer and a second location on the first subject's body for placing a second transducer. This may include, for example, comparing simulation results of multiple transducer location pairs and ranking and recommending transducer location pairs based on expected electric field distribution.
[0033] In step S908, the method 900 includes receiving molecular imaging data including a concentration of a target molecule (e.g., [18F]DASA-23) in a target region of the first subject's body after inducing an electric field between a first transducer disposed at a first location on the first subject's body and a second transducer disposed at a second location on the first subject's body. In step S910, the method 900 includes adjusting one or more parameters of the simulation algorithm based on the concentration of the target molecule in the target region of the first subject's body to generate an updated simulation algorithm. The simulation may be automatically adjusted based on the [18F]DASA-23 signal in a manner expected to improve the accuracy of future simulations and resulting transducer location recommendations. These updates are intended to generate a more uniform TT field distribution (represented by a uniform distribution of [18F]DASA-23) when applying future TT fields.
[0034] The method 900 may include receiving image data 912 associated with the body of the second subject, similar to the image data 702 of FIG. 7. In step S914, the method 900 includes performing one or more second simulations of an expected electric field distribution through the target region of the body of the second subject using the updated simulation algorithm based on the image data 912 associated with the body of the second subject. In step S916, the method 900 includes determining a first location on the body of the second subject for placing the first transducer and a second location on the body of the second subject for placing the second transducer based on the second simulation of step S914. That is, the updated simulation generated based on the feedback of applying the TT field to the body of the first subject can be used to improve the positioning of the transducer on the body of the other subject. In some embodiments, the updated simulation algorithm (S910) can be used to perform a simulation (S914) and determine a new location of the transducer on the body of the first subject (S916).
[0035] S908-S916 may be repeated on the same subject's body or on a different subject's body. For example, method 900 includes receiving molecular imaging data including a concentration of a target molecule in a target region of the second subject's body after an electric field is induced between a first transducer disposed at a first location on the second subject's body and a second transducer disposed at a second location on the second subject's body (S908); adjusting one or more parameters of the simulation algorithm based on the concentration of the target molecule in the target region of the second subject's body to generate a second updated simulation algorithm (S910); receiving image data associated with a third subject's body (S912); performing one or more third simulations of an expected electric field distribution through the target region of the third subject's body using the second updated simulation algorithm based on the image data associated with the third subject's body (S914); and determining a first location on the third subject's body for placing the first transducer and a second location on the third subject's body for placing the second transducer based on the third simulation (S916). This process can be repeated for target regions of any number of subjects to further calibrate and improve the accuracy of the simulation algorithm.
[0036] FIG. 10 is a flow chart illustrating an exemplary method 1000 of applying a TT field to a region of interest in a subject's body. In step S1002, the method 1000 includes placing a pair of transducers at a first pair of positions on the subject's body. In step S1004, the method 1000 includes inducing an electric field between the pair of transducers placed at the first positions on the subject's body, and in step S1006, terminating the electric field. After terminating the electric field, in step S1008, the method 1000 performs molecular imaging of the subject's body to determine a concentration of a target molecule in the region of interest. In step S1010, the method 1000 includes determining an updated first pair of positions on the subject's body for placing the pair of transducers based on the concentration of the target molecule. In step S1012, the method 1000 includes moving the pair of transducers to the updated first pair of positions on the subject, and inducing another electric field between the pair of transducers in step S1014. Steps S1006-S1014 of method 1000 may be repeated multiple times at regular intervals throughout treatment of the subject using the TT field.
[0037] The invention includes the following other exemplary embodiments ("embodiments").
[0038] Embodiment 1: A computer-implemented method for determining placement of transducers on a subject's body for applying a tumor treatment field, the computer including one or more processors and a memory accessible by one or more of the processors, the memory storing instructions that, when executed by one or more of the processors, cause the computer to execute the method, the method comprising: determining a first pair of locations on the subject's body for placing a pair of transducer arrays based on image data of the subject; receiving from a molecular imaging device a concentration of a target molecule detected within a target region of the subject's body, the concentration of the target molecule being detected after a tumor treatment field is induced between the pair of transducer arrays placed at the first location; determining how the tumor treatment field is distributed within the target region of the subject based on the detected concentration of the target molecule; determining a recommendation of a second pair of locations on the subject's body for placing a pair of transducer arrays based on the distribution of the tumor treatment field within the target region of the subject's body; and outputting the recommendation of the second pair of locations to a user.
[0039] Embodiment 2: The computer-implemented method of embodiment 1, wherein the target molecule comprises [18F]DASA-23.
[0040]
[0023] Embodiment 3: The computer-implemented method of embodiment 1, wherein said molecular imaging device comprises a pyruvate kinase M2 (PKM2) probe.
[0041] Embodiment 4: A computer-implemented method of embodiment 1, further comprising the steps of updating image data of the subject based on a distribution of tumor treatment fields within the target region, and determining a recommendation for a second pair of positions on the subject's body based on the updated image data.
[0042] Embodiment 5: The computer-implemented method of embodiment 1 further includes a step of aligning an image indicating a concentration of a target molecule in the segment of the target area with image data in the segment of the target area to generate a revised tumor segmentation, the tumor segmentation including a target molecule value in each pixel or voxel associated with the tumor, and a step of determining a recommendation for a second pair of locations on the subject's body based on the revised tumor segmentation.
[0043] Embodiment 6: The computer-implemented method of embodiment 1, wherein a second pair of locations on the subject's body is different from the first pair of locations on the subject's body if it is determined that the distribution of the tumor treatment field within the target region is sub-optimal.
[0044] Embodiment 7: The computer-implemented method of embodiment 1, wherein the second pair of locations on the subject's body are the same as the first pair of locations on the subject's body.
[0045] Embodiment 8: A computer-implemented method of embodiment 1, further comprising the steps of receiving an initial concentration of a target molecule in a target region of the subject's body from the molecular imaging device, and determining a recommendation for a second pair of locations on the subject's body based on a comparison of the initial concentration of the target molecule and the concentration of the target molecule detected in the target region.
[0046] Embodiment 9: The computer-implemented method of embodiment 8, wherein the step of determining how the tumor treatment field is distributed within the target area generates a heatmap visualization or statistical summary of the changes in the amount of the target molecule.
[0047] Embodiment 10: The computer-implemented method of embodiment 8, further comprising a step of determining a first pair of positions on the subject's body for placing the pair of transducer arrays based on image data of the subject's body and an initial concentration of target molecules in the target area.
[0048] Embodiment 11: The computer-implemented method of embodiment 1, wherein the step of determining how the tumor treatment field is distributed within a target area comprises generating a heatmap visualization or statistical summary of target molecular weights.
[0049] Embodiment 12: The computer-implemented method of embodiment 1, further comprising the steps of selecting a number of location pairs on the subject's body for placing the pair of transducer arrays, and for each of the location pairs, simulating an expected electric field distribution through the target region for an electric field induced between the pair of transducer arrays at that location pair, and determining the recommended second location pair to be the location pair that, through the simulation, results in at least one of a minimum variance in the electric field distribution within the target region while maintaining at least a predetermined electric field strength within the target region, or a maximum electric field strength in portions of the target region where the tumor treatment field does not reach a predetermined electric field strength.
[0050] Embodiment 13: The computer-implemented method of embodiment 1, further comprising the steps of selecting a number of location pairs on the subject's body for placing the pair of transducer arrays, and for each of the location pairs, simulating an expected electric field distribution through the target region for an electric field induced between the pair of transducer arrays at that location pair, and determining the recommended second location pair to be the location pair that, through the simulation, results in at least one of a minimum variance in the electric field distribution within the target region while maintaining at least a predetermined electric field strength within the target region, or a maximum electric field strength in a portion of the target region where the tumor treatment field does not reach a predetermined electric field strength.
[0051] Embodiment 14: The computer-implemented method of embodiment 1, further comprising determining a recommendation for a second position pair by applying a heuristic algorithm that suggests a change in position of the pair of transducer arrays that is expected to result in an increased distribution of tumor treatment fields within the target region.
[0052] Embodiment 15: A computer-implemented method for determining placement of transducers on a body of a subject to apply the tumor treating field, the computer including one or more processors and a memory accessible by one or more of the processors, the memory storing instructions that, when executed by one or more of the processors, cause the computer to perform the method, the method including the steps of: performing, using a simulation algorithm, one or more simulations of an expected electric field distribution through a target region of the first subject's body based on image data associated with the first subject; determining, based on the one or more simulations, a first location on the first subject's body for placing the first transducer and a second location on the first subject's body for placing the second transducer; receiving molecular imaging data including a concentration of a target molecule in a target region of the first subject's body after an electric field is induced between the first subject and a second transducer disposed at a second location on the first subject's body; adjusting one or more parameters of a simulation algorithm based on the concentration of the target molecule in the target region of the first subject's body to generate an updated simulation algorithm; receiving image data associated with the second subject's body; performing one or more second simulations of an expected electric field distribution through the target region of the second subject's body using the updated simulation algorithm based on the image data associated with the second subject's body; and determining a first location on the second subject's body for placing the first transducer and a second location on the second subject's body for placing the second transducer based on the one or more second simulations.
[0053] Embodiment 16: The computer-implemented method of embodiment 15, further comprising: performing one or more additional simulations of an expected electric field distribution through a target region of the first subject's body using the updated simulation algorithm based on image data associated with the first subject's body; and determining a recommendation of a second position pair for placing the first transducer and the second transducer on the first subject's body based on the one or more additional simulations.
[0054] Embodiment 17: The computer-implemented method of embodiment 15, further comprising the steps of: receiving molecular imaging data including a concentration of a target molecule in a target region of the second subject's body after an electric field is induced between the first transducer disposed at a first position on the body of the second subject and the second transducer disposed at a second position on the body of the second subject; adjusting one or more parameters of the simulation algorithm based on the concentration of the target molecule in the target region of the second subject's body to generate a second updated simulation algorithm; receiving image data associated with a third subject's body; performing one or more third simulations of an expected electric field distribution through the target region of the third subject's body using the second updated simulation algorithm based on the image data associated with the third subject's body; and determining a first position on the third subject's body for placing the first transducer and a second position on the third subject's body for placing the second transducer based on the one or more third simulations.
[0055] Embodiment 18: The computer-implemented method of embodiment 15, wherein the image data associated with the body of the first subject and the image data associated with the body of the second subject include at least one of magnetic resonance image data, computed tomography data, positron emission tomography data, or X-ray imaging data.
[0056] Embodiment 19: A method of applying a tumor treating field to a region of interest of a subject, the method comprising the steps of: placing a pair of transducers at a first location pair on the subject; inducing an electric field between the pair of transducers placed at the first location pair on the subject; terminating the electric field, and molecular imaging the subject's body after terminating the electric field to determine a concentration of a target molecule in the region of interest; determining an updated first location pair on the subject's body for placing the pair of transducers based on the concentration of the target molecule; moving the pair of transducers to the updated first location pair on the subject's body; and inducing another electric field between the pair of transducers.
[0057] Embodiment 20: The method of embodiment 19, further comprising the steps of updating a simulation algorithm based on a concentration of the target molecule, performing one or more simulations of an expected electric field distribution within a region of interest within the body of a second subject using the updated simulation algorithm, and determining a first pair of positions on the body of the second subject based on the one or more simulations.
[0058] Many modifications, variations, and variations of the described embodiments are possible without departing from the scope of the invention as defined in the claims. The invention is not limited to the described embodiments, but is intended to have the full scope defined by the language of the following claims and their equivalents. [Explanation of symbols]
[0059] 402 1st transducer 404 Second transducer 406 Electrode Element 408 Substrate 410 Conductive wiring 412 Electrode Element 414 Substrate 416 Conductive wiring 418 AC voltage generator 420 Controller 500 devices 502 processor 504 Memory 506 Output Device 508 Link 510 Input 600A, 600B, 600C MRI images 602A, 602B, 602C Modified tumor segmentation
Claims
1. 1. A computer-implemented method for determining transducer placement on a body of a subject to apply a tumor treatment field, the computer including one or more processors and a memory accessible by one or more of said processors, the memory storing instructions that, when executed by one or more of said processors, cause the computer to perform the method, the method comprising: determining a first pair of locations on the subject's body for placing a pair of transducer arrays based on image data of the subject's body; receiving from a molecular imaging device a concentration of a target molecule detected within a target region of the subject's body, the concentration of the target molecule detected after a tumor treatment field is induced between a pair of transducer arrays disposed at the first location pair; determining how the tumor treating field is distributed within a target region of the subject's body based on the detected concentrations of the target molecules; determining a recommendation for a second pair of locations on the subject's body for placing a pair of transducer arrays based on a distribution of the tumor treatment fields within a target region of the subject's body; and outputting the second location pair recommendation to the user.
2. 2. The computer-implemented method of claim 1, wherein the target molecule comprises [18F]DASA-23.
3. The computer-implemented method of claim 1 or 2, wherein the molecular imaging device comprises a pyruvate kinase M2 (PKM2) probe.
4. Based on the distribution of tumor treatment fields within the target area, updating the image data of the subject's body; The computer-implemented method of claim 1 , 2 or 3 , further comprising: determining a recommendation for a second pair of positions on the subject's body based on the updated image data.
5. registering an image indicating a concentration of a target molecule in the segment of the target area with image data in the segment of the target area to generate a revised tumor segmentation; the revised tumor segmentation including a target molecule value in each pixel or voxel associated with the tumor; The computer-implemented method of claim 1 , further comprising: determining a recommendation for a second pair of locations on the subject's body based on the revised tumor segmentation.
6. A second pair of locations on the subject's body: different from the first pair of locations on the subject's body if a distribution of tumor treatment fields within the target region is determined to be sub-optimal; or The computer-implemented method of claim 1 , wherein the first pair of positions on the subject's body are the same as the first pair of positions on the subject's body.
7. receiving from the molecular imaging device an initial concentration of a target molecule within a target region of the subject's body; and determining a recommendation for a second pair of locations on the subject's body based on a comparison of the initial concentration of the target molecule and the detected concentration of the target molecule in the target area, and optionally, 7. The computer-implemented method of claim 1, wherein the step of determining how the tumor treatment field is distributed within the target region comprises generating a heatmap visualization or statistical summary of changes in the amount of the target molecule.
8. Based on the image data of the subject's body and the initial concentration of the target molecule within the target region, The computer-implemented method of claim 7 , further comprising determining a first pair of locations on a subject's body for placing the pair of transducer arrays.
9. 7. The computer-implemented method of claim 1, wherein the step of determining how the tumor treatment field is distributed within the target area comprises generating a heatmap visualization or statistical summary of the amount of the target molecule.
10. selecting a plurality of pairs of locations on the subject's body for placing the pairs of transducer arrays; for each pair of locations, simulating an expected electric field distribution through the target area for an electric field induced between a pair of transducer arrays at the pair of locations; The second location pair is recommended by simulation. a minimal variance in the electric field distribution within the target region while maintaining at least a predetermined electric field strength within the target region; or 10. The computer-implemented method of claim 1, further comprising: determining that the tumor treatment field is a location pair resulting in at least one maximum electric field strength in a portion of the target region that did not reach a predetermined electric field strength.
11. 10. The computer-implemented method of claim 1, further comprising determining a recommendation for a second pair of positions by applying a heuristic algorithm that suggests changes in the positions of the pair of transducer arrays that are expected to result in an increased distribution of a tumor treatment field within the target region.
12. 1. A computer-implemented method for determining placement of transducers on a body of a subject to apply a tumor treatment field, the computer including one or more processors and memory accessible by one or more of said processors, the memory storing instructions that, when executed by one or more of said processors, cause the computer to perform the method, the method comprising: performing, using a simulation algorithm, one or more simulations of an expected electric field distribution through a target region of a body of a first subject based on image data associated with the first subject; determining a first location on the first subject's body for placing a first transducer and a second location on the first subject's body for placing a second transducer based on the one or more simulations; receiving molecular imaging data including a concentration of a target molecule in a target region of the first subject's body after an electric field is induced between a first transducer disposed at a first location on the first subject's body and a second transducer disposed at a second location on the first subject's body; adjusting one or more parameters of a simulation algorithm based on a concentration of a target molecule in a target region of the first subject's body to generate an updated simulation algorithm; receiving image data associated with a body of a second subject; performing one or more second simulations of expected electric field distribution through a target region of the second subject's body using the updated simulation algorithm based on image data associated with the second subject's body; and determining a first location on the second subject's body for placing the first transducer and a second location on the second subject's body for placing the second transducer based on the one or more second simulations.
13. Based on image data associated with the first subject's body, performing one or more additional simulations of expected electric field distribution through a target region of the first subject's body using the updated simulation algorithm; 13. The computer-implemented method of claim 12, further comprising: determining a recommendation of a second pair of positions for placing the first transducer and the second transducer on the first subject's body based on the one or more additional simulations.
14. receiving molecular imaging data including a concentration of a target molecule in a target region of the second subject's body after an electric field is induced between the first transducer disposed at a first location on the second subject's body and the second transducer disposed at a second location on the second subject's body; adjusting one or more parameters of the simulation algorithm based on a concentration of a target molecule in a target region of the second subject's body to generate a second updated simulation algorithm; receiving image data associated with a body of a third subject; performing one or more third simulations of expected electric field distributions through a target region of the third subject's body using the second updated simulation algorithm based on image data associated with the third subject's body; 14. The computer-implemented method of claim 12 or 13, further comprising: determining, based on the one or more third simulations, a first location on the third subject's body for placing the first transducer and a second location on the third subject's body for placing the second transducer.
15. 15. The computer-implemented method of claim 12, 13 or 14, wherein image data associated with the first subject's body and image data associated with the second subject's body comprise at least one of magnetic resonance image data, computed tomography data, positron emission tomography data, or x-ray imaging data.
Citation Information
Patent Citations
TTFIELD therapy with optimized electrode positions on the head based on MRI conductivity measurements
JP2019500179A
Methods and apparatuses for optimizing transducer array placement
WO2021111186A1
Methods of normalizing aberrant glycolytic metabolism in cancer cells
WO2021134010A1
Methods, systems, and apparatuses for guiding transducer placements for tumor treating fields
WO2021198882A1
